CytoImmune Therapeutics | Wells Fargo Healthcare Conference Session:
September, 2021
CytoImmune Therapeutics | Wells Fargo Healthcare Conference
on
Join the CytoImmune Therapeutics | Wells Fargo Healthcare Conference
About CytoImmune Therapeutics, Inc.
CytoImmune Therapeutics is a clinical-stage biotechnology company founded in 2017. It is focused on developing a portfolio of natural killer (NK) immunotherapies designed to utilize the power of a patient’s own immune system to eliminate cancer cells. CytoImmune is moving towards filing the Investigational New Drug (IND) applications for novel immunotherapy programs in hematological and solid malignancies.
Contact:
Name: Alice Mior
Phone: +57 312 8113601
Email: [email protected]
SOURCE: CytoImmune Therapeutics